Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study

被引:21
作者
Zaal, Rianne J. [1 ]
Ebbers, Susan [2 ]
Borms, Mirka [3 ]
de Koning, Bart [4 ]
Mombarg, Erna [5 ]
Ooms, Piet [6 ]
Vollaard, Hans [7 ]
van den Bemt, Patricia M. L. A. [1 ]
Evenhuis, Heleen M. [8 ]
机构
[1] Erasmus MC, Dept Hosp Pharm, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] DeSeizoenen, Oploo, Netherlands
[3] Raamwerk, Noordwijkerhout, Netherlands
[4] Pluryn, Nijmegen, Netherlands
[5] Apotheek MC Wieenhof, Venray, Netherlands
[6] Katwijkse Apotheek, Katwijk, Netherlands
[7] Sint Maartensklin, Nijmegen, Netherlands
[8] Erasmus MC, Dept Gen Practice, Intellectual Disabil Med, Rotterdam, Netherlands
关键词
Intellectual disability; Polypharmacy; Drug-related problems; STOPP/START criteria; DRUG-RELATED PROBLEMS; OLDER-PEOPLE; INFORMED-CONSENT; RISK-FACTORS; INDIVIDUALS; PREVALENCE; PHARMACISTS; IDENTIFICATION; POLYPHARMACY; HOSPITALS;
D O I
10.1016/j.ridd.2016.03.014
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
A Systematic Tool to Reduce Inappropriate Prescribing (STRIP), which includes the Screening Tool to Alert doctors to Right Treatment (START) and the Screening Tool of Older Peoples' Prescriptions (STOPP), has recently been developed in the Netherlands for older patients with polypharmacy in the general population. Active involvement of the patient is part of this systematic multidisciplinary medication review. Although annual review of pharmacotherapy is recommended for people with an intellectual disability (ID), a specific tool for this population is not yet available. Besides, active involvement can be compromised by ID. Therefore, the objective of this observational pilot study was to evaluate the process of medication review using STRIP in adults with an ID living in a centralized or dependent setting and the identification of drug-related problems using this tool. The study was performed in three residential care organizations for ID. In each organization nine clients with polypharmacy were selected by an investigator (a physician in training to become a specialized physician for individuals with an ID) for a review using STRIP. Clients as well as their legal representatives (usually a family member) and professional caregivers were invited to participate. Reviews were performed by an investigator together with a pharmacist. First, to evaluate the process time-investments of the investigator and the pharmacist were described. Besides, the proportion of reviews in which a client and/or his legal representative participated was calculated as well as the proportion of professional caregivers that participated. Second, to evaluate the identification of drug-related problems using STRIP, the proportion of clients with at least one drug-related problem was calculated. Mean time investment was 130 minutes for the investigator and 90 minutes for the pharmacist. The client and/or a legal representatives were present during 25 of 27 reviews (93%). All 27 professional caregivers (100%) were involved. For every client included at least one drug related problem was identified. In total 127 drug-related problems were detected, mainly potentially inappropriate or unnecessary drugs. After six months, 15.7% of the interventions were actually implemented. Medication review using STRIP seems feasible in adults with an ID and identifies drug related problems. However, in this pilot study the implementation rate of suggested interventions was low. To improve the implementation rate, the treating physician should be involved in the review process. Besides, specific adaptations to STRIP to address drug related problems specific for this population are required. (c) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:132 / 142
页数:11
相关论文
共 44 条
[1]   Assessing the ability of people with a learning disability to give informed consent to treatment [J].
Arscott, K ;
Dagnan, D ;
Kroese, BS .
PSYCHOLOGICAL MEDICINE, 1999, 29 (06) :1367-1375
[2]   A study of the knowledge that people with intellectual disabilities have of their prescribed medication [J].
Arscott, K ;
Kroese, BS ;
Dagnan, D .
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2000, 13 (02) :90-99
[3]  
BEANGE H, 1995, AM J MENT RETARD, V99, P595
[4]   Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory [J].
Bedouch, P. ;
Sylvoz, N. ;
Charpiat, B. ;
Juste, M. ;
Roubille, R. ;
Rose, F. -X. ;
Bosson, J. -L. ;
Conort, O. ;
Allenet, B. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (01) :32-40
[5]   The prevalence of constipation in institutionalized people with intellectual disability [J].
Böhmer, CJM ;
Taminiau, JAJM ;
Klinkenberg-Knol, EC ;
Meuwissen, SGM .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2001, 45 :212-218
[6]   Gastroesophageal reflux disease in intellectually disabled individuals:: How often, how serious, how manageable? [J].
Böhmer, CJM ;
Klinkenberg-Knol, EC ;
Niezen-de Boer, MC ;
Meuwissen, SGM .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (08) :1868-1872
[7]   Acceptance and importance of clinical pharmacists' LIMM-based recommendations [J].
Bondesson, Asa ;
Holmdahl, Lydia ;
Midlov, Patrik ;
Hoglund, Peter ;
Andersson, Emmy ;
Eriksson, Tommy .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (02) :272-276
[8]   Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit [J].
Bourne, Richard S. ;
Choo, Chui Lynn .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (02) :351-357
[9]   Inappropriate prescribing according to the STOPP/START criteria in older people from a primary care setting [J].
Castillo-Paramo, Alicia ;
Claveria, Ana ;
Verdejo Gonzalez, Asuncion ;
Gomez-Serranillos, Isabel Rey ;
Fernandez-Merino, M. Carmen ;
Figueiras, Adolfo .
EUROPEAN JOURNAL OF GENERAL PRACTICE, 2014, 20 (04) :281-289
[10]   Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription [J].
de Kuijper, G. ;
Hoekstra, P. ;
Visser, F. ;
Scholte, F. A. ;
Penning, C. ;
Evenhuis, H. .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2010, 54 :659-667